Quantcast

Latest Biosimilar Stories

2014-11-21 04:21:49

DALLAS, November 21, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science

2014-11-19 12:25:57

Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,

2014-11-17 23:01:58

FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs Washington D.C.

2014-11-17 12:27:24

FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs WASHINGTON, Nov.

2014-11-11 16:23:45

Surveyed German Nephrologists Report that the Majority of Their Patients Treated with Epoetin Alfa Receive a Biosimilar, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-11-04 12:28:43

Novel Therapies Demonstrating Evidence of Superior Head-to-Head Efficacy Will Expand the Role of Adjunct Therapy, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.

2014-10-29 16:28:36

Payers Employ a Variety of Cost-Control Measures to Manage the Utilization of Premium-Priced RA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.

2014-10-27 23:10:29

FDA has published a newlist of licensed biological products and interchangeable biosimilars, the “Purple Book”, which is being hyped as being the biological equivalent of the pharmaceutical

2014-10-22 20:23:26

Launches discussion about the future of biosimilars in Italy ROME, Oct.

2014-10-18 23:00:29

North America is the largest contributor to the global market while Asia is expected to grow at the highest rate.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related